U.S. stocks fell Thursday, led by tech, while energy rose and oil jumped 4.8%. Jobless claims eased

Medicus Pharma (NASDAQ:MDCX) is positioning its precision oncology-led pipeline for a series of clin

PHILADELPHIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the

Applied Digital shares rise after Q1 revenue and loss beat estimates; Xiao-I and iPower lead gainers

Medicus Pharma shares fall 24% after hours as the company announces a 50-to-1 share consolidation.

Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market sessio

Medicus Pharma (NASDAQ:MDCX) has submitted a seamless Phase 2b/3 registration-intent protocol to the

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided,

Proposed seamless design would incorporate previously FDA-cleared dose-optimization work into a sing

Medicus Pharma (NASDAQ:MDCX) said it will focus future internally sponsored clinical development of

Medicus Pharma narrows SkinJect development to Gorlin syndrome, targeting a $1.1 billion market and

PHILADELPHIA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd.

On September 11, 2026, Medicus Pharma Ltd. (the "Company") and YA II PN, LTD. ("Yorkvill

Medicus Pharma (NASDAQ:MDCX) earlier this week outlined progress across its SkinJect program and a c

Positive tone Wall Street opened sharply higher on Friday, with the Dow Jones Industrial Average and

Medicus Pharma (NASDAQ:MDCX) said a completed Phase 2 study of its SkinJect therapy showed all 90 en

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided,

CSR provides a clinical foundation for the Company's recently announced capital-efficient focus on F

10:05am: Rising yields pressure stocks Stocks moved lower at the open on Thursday as Treasury yields

4:20pm: Treasury yields climb Wall Street extended its selloff on Wednesday, with the Dow Jones Indu

Medicus Pharma (NASDAQ:MDCX) is repositioning itself as a precision oncology-led biotechnology compa

Company prioritizes CD228V precision oncology development in Melanoma while pursuing capital-efficie

Medicus Pharma Ltd. (NASDAQ:MDCX) secured on Wednesday an exclusive, sublicensable global license fr

Medicus Pharma partners with Pfizer to commercialize CD228V in a licensing deal worth over $1 billio

Gainers Cypherpunk Technologies (NASDAQ:CYPH) shares rose 30.4% to $2.19 during Thursday's regu

U.S. stocks climbed, led by Nasdaq; communications shares rose, energy fell, while MIMI surged and R

Gainers Gelteq (NASDAQ:GELS) shares increased by 38.6% to $0.97 during Thursday's pre-market se

Medicus Pharma (NASDAQ:MDCX) has reported second quarter financial results and regulatory and clinic

Company Highlights Significant Regulatory, Clinical and Strategic Progress Across SkinJect® and Teve

SK Hynix Inc (NASDAQ:SKHY) has received an ‘Outperform’ rating from Wedbush on Tuesday as the firm i

Medicus Pharma (NASDAQ:MDCX) announced it has put its chief medical officer in charge of UK subsidia

Dr. Mehmud's appointment further aligns the scientific, clinical, regulatory and operational leaders

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Frida

Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the compan

J B Hunt Transport Services Inc (JBHT) stock rose in pre-market trading after beating earnings estim

ZVRA up in pre-market trading on better-than-expected Q4 results. Gainers include BRTX, COOT, BIYA,

Dow down 800 points, S&P 500 and NASDAQ also fall. Energy sector rises, healthcare dips. BJ repo

US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6